Use of melanotan I and II in the general population.
Evans-Brown
Michael
M
Dawson
Rob T
RT
Chandler
Martin
M
McVeigh
Jim
J
D006801:Humans; D008297:Male; D004366:Nonprescription Drugs / Q000008:administration & dosage / Q000009:adverse effects; D010410:Penile Erection / Q000187:drug effects; D010456:Peptides, Cyclic / Q000008:administration & dosage / Q000009:adverse effects; D019966:Substance-Related Disorders / Q000209:etiology*; D055107:Suntan / Q000187:drug effects*; D000521:alpha-MSH / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*
D004366:Nonprescription Drugs; D010456:Peptides, Cyclic; C079282:melanotan-II; D000521:alpha-MSH; C027756:MSH, 4-Nle-7-Phe-alpha-